Annual Net Income
-$10.55 M
-$24.22 M-177.14%
31 December 2023
Summary:
Pharming Group NV annual net profit is currently -$10.55 million, with the most recent change of -$24.22 million (-177.14%) on 31 December 2023. During the last 3 years, it has fallen by -$48.29 million (-127.94%). PHAR annual net income is now -126.01% below its all-time high of $40.56 million, reached on 31 December 2019.PHAR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$1.03 M
+$184.00 K+15.11%
30 September 2024
Summary:
Pharming Group NV quarterly net profit is currently -$1.03 million, with the most recent change of +$184.00 thousand (+15.11%) on 30 September 2024. Over the past year, it has dropped by -$4.50 million (-129.85%). PHAR quarterly net income is now -106.11% below its all-time high of $16.93 million, reached on 31 December 2014.PHAR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$17.82 M
-$4.50 M-33.76%
30 September 2024
Summary:
Pharming Group NV TTM net profit is currently -$17.82 million, with the most recent change of -$4.50 million (-33.76%) on 30 September 2024. Over the past year, it has increased by +$4.23 million (+19.19%). PHAR TTM net income is now -139.17% below its all-time high of $45.51 million, reached on 30 June 2020.PHAR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -177.1% | -129.8% | +19.2% |
| 3 y3 years | -127.9% | -146.8% | -182.4% |
| 5 y5 years | -136.9% | -109.5% | -146.0% |
PHAR Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -127.9% | at low | -106.6% | +92.9% | -158.7% | +19.2% |
| 5 y | 5 years | -126.0% | at low | -106.6% | +92.9% | -139.2% | +19.2% |
| alltime | all time | -126.0% | +88.5% | -106.1% | +97.8% | -139.2% | +80.5% |
Pharming Group NV Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.03 M(-15.1%) | -$17.82 M(+33.8%) |
| June 2024 | - | -$1.22 M(-90.2%) | -$13.32 M(+23.5%) |
| Mar 2024 | - | -$12.45 M(+298.6%) | -$10.79 M(+2.3%) |
| Dec 2023 | -$10.55 M(-177.1%) | -$3.12 M(-190.2%) | -$10.55 M(-52.2%) |
| Sept 2023 | - | $3.46 M(+162.6%) | -$22.05 M(+34.3%) |
| June 2023 | - | $1.32 M(-110.8%) | -$16.42 M(+723.0%) |
| Mar 2023 | - | -$12.21 M(-16.6%) | -$2.00 M(-114.6%) |
| Dec 2022 | $13.67 M(-14.5%) | -$14.63 M(-260.8%) | $13.67 M(-55.0%) |
| Sept 2022 | - | $9.10 M(-42.2%) | $30.37 M(+45.7%) |
| June 2022 | - | $15.74 M(+354.8%) | $20.85 M(+90.7%) |
| Mar 2022 | - | $3.46 M(+67.8%) | $10.93 M(-31.6%) |
| Dec 2021 | $16.00 M(-57.6%) | $2.06 M(-592.4%) | $16.00 M(-26.0%) |
| Sept 2021 | - | -$419.00 K(-107.2%) | $21.63 M(-31.8%) |
| June 2021 | - | $5.83 M(-31.6%) | $31.69 M(-14.3%) |
| Mar 2021 | - | $8.52 M(+10.8%) | $36.97 M(-2.0%) |
| Dec 2020 | $37.75 M(-6.9%) | $7.69 M(-20.2%) | $37.75 M(-14.8%) |
| Sept 2020 | - | $9.65 M(-13.2%) | $44.29 M(-2.7%) |
| June 2020 | - | $11.11 M(+19.5%) | $45.51 M(+7.6%) |
| Mar 2020 | - | $9.29 M(-34.7%) | $42.28 M(+4.3%) |
| Dec 2019 | $40.56 M(+41.9%) | $14.24 M(+31.1%) | $40.56 M(+4.6%) |
| Sept 2019 | - | $10.86 M(+37.7%) | $38.78 M(+13.4%) |
| June 2019 | - | $7.89 M(+4.2%) | $34.20 M(+16.4%) |
| Mar 2019 | - | $7.57 M(-39.3%) | $29.39 M(+2.8%) |
| Dec 2018 | $28.59 M(-131.3%) | $12.46 M(+98.5%) | $28.59 M(-192.0%) |
| Sept 2018 | - | $6.28 M(+103.9%) | -$31.07 M(-34.0%) |
| June 2018 | - | $3.08 M(-54.5%) | -$47.06 M(-40.1%) |
| Mar 2018 | - | $6.77 M(-114.3%) | -$78.56 M(-14.1%) |
| Dec 2017 | -$91.47 M(+396.0%) | -$47.20 M(+386.1%) | -$91.47 M(+79.3%) |
| Sept 2017 | - | -$9.71 M(-65.8%) | -$51.01 M(+12.1%) |
| June 2017 | - | -$28.43 M(+362.8%) | -$45.52 M(+119.4%) |
| Mar 2017 | - | -$6.14 M(-8.7%) | -$20.75 M(+12.5%) |
| Dec 2016 | -$18.44 M | -$6.73 M(+59.5%) | -$18.44 M(+15.6%) |
| Sept 2016 | - | -$4.22 M(+15.5%) | -$15.96 M(+10.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | -$3.65 M(-4.7%) | -$14.47 M(+8.9%) |
| Mar 2016 | - | -$3.84 M(-9.7%) | -$13.28 M(+22.0%) |
| Dec 2015 | -$10.89 M(+55.2%) | -$4.25 M(+55.8%) | -$10.89 M(-205.7%) |
| Sept 2015 | - | -$2.73 M(+10.3%) | $10.30 M(-22.1%) |
| June 2015 | - | -$2.47 M(+72.0%) | $13.21 M(-2.9%) |
| Mar 2015 | - | -$1.44 M(-108.5%) | $13.60 M(-294.0%) |
| Dec 2014 | -$7.01 M(-66.3%) | $16.93 M(+8998.8%) | -$7.01 M(-76.4%) |
| Sept 2014 | - | $186.10 K(-108.9%) | -$29.77 M(-16.2%) |
| June 2014 | - | -$2.08 M(-90.6%) | -$35.54 M(-1.0%) |
| Mar 2014 | - | -$22.05 M(+278.6%) | -$35.89 M(+72.6%) |
| Dec 2013 | -$20.80 M(-34.7%) | -$5.82 M(+4.3%) | -$20.80 M(+31.7%) |
| Sept 2013 | - | -$5.59 M(+130.0%) | -$15.79 M(-22.2%) |
| June 2013 | - | -$2.43 M(-65.1%) | -$20.28 M(-32.8%) |
| Mar 2013 | - | -$6.96 M(+754.1%) | -$30.17 M(-5.3%) |
| Dec 2012 | -$31.86 M(+43.7%) | -$814.50 K(-91.9%) | -$31.86 M(-10.6%) |
| Sept 2012 | - | -$10.08 M(-18.1%) | -$35.64 M(+12.8%) |
| June 2012 | - | -$12.32 M(+42.4%) | -$31.59 M(+22.7%) |
| Mar 2012 | - | -$8.65 M(+88.5%) | -$25.74 M(+16.1%) |
| Dec 2011 | -$22.17 M(-66.8%) | -$4.59 M(-24.0%) | -$22.17 M(-40.4%) |
| Sept 2011 | - | -$6.04 M(-6.6%) | -$37.20 M(-7.4%) |
| June 2011 | - | -$6.46 M(+27.2%) | -$40.18 M(-30.1%) |
| Mar 2011 | - | -$5.08 M(-74.1%) | -$57.49 M(-8.4%) |
| Dec 2010 | -$66.78 M(+45.4%) | -$19.62 M(+117.6%) | -$62.75 M(+13.6%) |
| Sept 2010 | - | -$9.02 M(-62.1%) | -$55.22 M(-4.7%) |
| June 2010 | - | -$23.77 M(+129.9%) | -$57.93 M(+23.0%) |
| Mar 2010 | - | -$10.34 M(-14.5%) | -$47.10 M(+4.7%) |
| Dec 2009 | -$45.93 M(+25.9%) | -$12.09 M(+3.1%) | -$45.01 M(+36.7%) |
| Sept 2009 | - | -$11.73 M(-9.3%) | -$32.91 M(+55.4%) |
| June 2009 | - | -$12.94 M(+56.9%) | -$21.18 M(+156.9%) |
| Mar 2009 | - | -$8.24 M | -$8.24 M |
| Dec 2008 | -$36.48 M(+15.6%) | - | - |
| Dec 2007 | -$31.55 M(+29.3%) | - | - |
| Dec 2006 | -$24.41 M(+15.4%) | - | - |
| Dec 2005 | -$21.15 M | - | - |
FAQ
- What is Pharming Group NV annual net profit?
- What is the all time high annual net income for Pharming Group NV?
- What is Pharming Group NV annual net income year-on-year change?
- What is Pharming Group NV quarterly net profit?
- What is the all time high quarterly net income for Pharming Group NV?
- What is Pharming Group NV quarterly net income year-on-year change?
- What is Pharming Group NV TTM net profit?
- What is the all time high TTM net income for Pharming Group NV?
- What is Pharming Group NV TTM net income year-on-year change?
What is Pharming Group NV annual net profit?
The current annual net income of PHAR is -$10.55 M
What is the all time high annual net income for Pharming Group NV?
Pharming Group NV all-time high annual net profit is $40.56 M
What is Pharming Group NV annual net income year-on-year change?
Over the past year, PHAR annual net profit has changed by -$24.22 M (-177.14%)
What is Pharming Group NV quarterly net profit?
The current quarterly net income of PHAR is -$1.03 M
What is the all time high quarterly net income for Pharming Group NV?
Pharming Group NV all-time high quarterly net profit is $16.93 M
What is Pharming Group NV quarterly net income year-on-year change?
Over the past year, PHAR quarterly net profit has changed by -$4.50 M (-129.85%)
What is Pharming Group NV TTM net profit?
The current TTM net income of PHAR is -$17.82 M
What is the all time high TTM net income for Pharming Group NV?
Pharming Group NV all-time high TTM net profit is $45.51 M
What is Pharming Group NV TTM net income year-on-year change?
Over the past year, PHAR TTM net profit has changed by +$4.23 M (+19.19%)